Park Medi World Limited (NSE:PARKHOSPS)

India · Delayed Price · Currency is INR

256.40

-1.79 (-0.69%)

Nov 12, 2026, 3:29 PM IST

Market Cap	110.75B
Revenue (ttm)	17.56B +21.4%
Net Income	2.83B +34.9%
EPS	7.23 +28.9%
Shares Out	431.93M
PE Ratio	35.48
Forward PE	28.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	763,501
Open	259.74
Previous Close	258.19
Day's Range	250.00 - 260.70
52-Week Range	138.10 - 305.00
Beta	n/a
Analysts	Strong Buy
Price Target	362.50 (+41.38%)
Earnings Date	Nov 13, 2026

About Park Medi World

Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paed... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2005

Employees 6,423

Stock Exchange National Stock Exchange of India

Ticker Symbol PARKHOSPS

Full Company Profile

Financial Performance

In fiscal year 2026, Park Medi World's revenue was 16.79 billion, an increase of 20.51% compared to the previous year's 13.94 billion. Earnings were 2.58 billion, an increase of 28.01%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for PARKHOSPS stock is "Strong Buy." The 12-month stock price target is ₹362.50, which is an increase of 41.38% from the latest price.

Price Target

₹362.50

(41.38% upside)

Analyst Consensus: Strong Buy

Stock Forecasts